The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -32.08% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -50.82%. Over the past 30 days, the price of PRQR has fallen by 41.73%. And in the last five days, it has surged by 16.88%.
ProQR Therapeutics N.V’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $4.62 on 10/17/24, and the lowest price during the same period was recorded at $1.07 on 04/09/25.
52-week price history of PRQR Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. ProQR Therapeutics N.V’s current trading price is -61.04% away from its 52-week high, while its distance from the 52-week low is 68.22%. The stock’s price range over this timeframe has been between $1.07 and $4.62. The shares of the Healthcare sector company recorded a trading volume of approximately 0.88 million for the day, which was comparatively higher than the average daily volume of 0.58 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
ProQR Therapeutics N.V (PRQR) has experienced a quarterly decline of -20.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 189.38M.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0622, with a change in price of -1.7600. Similarly, ProQR Therapeutics N.V recorded 534,121 in trading volume during the last 100 days, posting a change of -49.44%.
PRQR’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PRQR stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.12.
PRQR Stock Stochastic Average
The raw stochastic average for ProQR Therapeutics N.V over the last 50 days is presently at 48.50%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 77.25%. Further, the company’s Stochastic %K and %D values for the last 20 days were 89.68% and 91.26%, respectively.
